Anne is Venture Consultant at Sofinnova Partners, she manages the medtech deal flow.
Anne Osdoit joined MD Start after spending 10 years developing Mauna Kea Technologies, a medical technology French start-up company with global operations, offering a disruptive “optical biopsy” technology. At Mauna Kea Technologies, Anne held various positions in clinical and regulatory development as well as marketing and sales support. She was also heavily involved in the different financing rounds as well as in the IPO process. She interfaced with the key opinion leaders and has an extensive network in the fields of endoscopy and surgery (digestive, pulmonary, and urological). Having lived and worked in hospital environments in the USA and in the UK, Anne can translate unmet medical needs into product projects and integrate regulatory and market access input and constraints from all around the world. She is currently the CEO of SafeHeal, one of the companies created, funded and incubated by MD Start II. Anne is an Board member of FeetMe (France) and the chairwoman of Cardiologs (France).
Anne is a trained biomedical engineer from Ecole Polytechnique of Paris, France and Johns Hopkins University in Baltimore, USA.